从社会角度估计埃及的前列腺癌成本
Gihan Hamdy Elsisi1,2, Mariam Mohamed El-Attar1, Shaimaa Mohamed Ismaeil3
1HTA Office, LLC, Cairo, Egypt.
Global journal on quality and safety in healthcare
|June 19, 2023
概括
转移性前列腺癌在埃及造成重大经济负担,每年耗资85.14亿埃及法郎. 早期治疗对于降低医疗保健成本和社会影响至关重要.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
背景情况:
- 前列腺癌是全球和埃及的重大健康问题.
- 了解前列腺癌的经济负担对于医疗保健政策和资源分配至关重要.
研究的目的:
- 评估埃及前列腺癌在一年时间内的总社会成本.
- 根据疾病状态来区分成本:局部化,激素敏感和转移性抵抗割的前列腺癌.
主要方法:
- 根据临床参数和人口数据的已发表文献,开发了一种疾病成本模型.
- 包括直接的医疗成本 (治疗,监测) 和间接成本.
- 单位成本来自埃及医疗机构,资源利用得到专家小组的验证.
主要成果:
- 局部性前列腺癌的年度总成本为EGP 41.44亿 (9.010亿美元),而转移性前列腺癌的成本为EGP 85.14亿 (18.510亿美元).
- 药物成本占局部和转移性疾病的大部分支出.
- 与局部性疾病 (EGP 0.29 亿) 相比,转移性前列腺癌 (EGP 3.76 亿) 的非药物成本要高得多,这表明随访增加和生产力下降.
结论:
- 转移性前列腺癌对埃及医疗保健系统造成了相当大的经济负担.
- 与转移性疾病相关的更高成本强调了早期诊断和治疗的重要性,以减轻患者和社会的财务压力.
更多相关视频
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.6K
07:34Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
716
相关概念视频
Disorders of the Male Reproductive System
474
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
474
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
